Biogen and Ionis near approval for spinal muscular atrophy drug
Biogen and Ionis Pharmaceuticals could soon deliver the first-ever treatment for spinal muscular atrophy. Meanwhile, carrier screening that could prevent the disorder goes unfunded.
carrier testing